Analytical study of MRI Brain in Antepartum and Postpartum Eclampsia patients by Kiritha Ranjani, A C
A DISSERTATION  
ON 
ANALYTICAL STUDY OF MRI BRAIN IN ANTEPARTUM 
AND POSTPARTUM ECLAMPSIA PATIENTS” 
Dissertation submitted to 
THE TAMIL NADU Dr.M.G.R. MEDICAL UNIVERISTY 
CHENNAI 
with partial fulfillment of the regulations 
for the Award of the degree 
M.S. [OBSTETRICS & GYNECOLOGY] 
 
Branch – II 
DEPARTMENT OF OBSTETRICS & GYNECOLOGY 
STANLEY MEDICAL COLLEGE  
CHENNAI 
APRIL - 2017
CERTIFICATE 
 
This is to certify that the dissertation entitled “ANALYTICAL 
STUDY OF MRI BRAIN IN ANTEPARTUM AND POSTPARTUM 
ECLAMPSIA PATIENTS” submitted by Dr. KIRITHA RANJANI. A.C, 
to the faculty of Obstetrics and Gynaecology, Stanley Medical College, The 
Tamilnadu Dr. M.G.R Medical University, Chennai,  in partial fulfillment of 
the requirements for the award of M.S Degree (OBSTETRICS & 
GYNECOLOGY) , is a bonafide research work carried out by her under our 
direct supervision and guidance. 
 
 
 
 
Dr. K. KALAIVANI, MD., DGO. , 
Professor and Head of the Department, 
Department of Obstetrics & Gynaecology, 
Stanley Medical College,                   
Chennai –1. 
 
 
Dr. ISSAC CHRISTIAN MOSES  
M.D., FICP FACP 
Dean 
Stanley Medical College and Hospital, 
Chennai-600001 
 
 
 
 
 
 
 
  
DECLARATION 
 
I, Dr. KIRITHA RANJANI.A.C solemnly declare that dissertation 
titled, “ANALYTICAL STUDY OF MRI BRAIN IN ANTEPARTUM 
AND POSTPARTUM ECLAMPSIA PATIENTS” is a bonafide work 
done by me at Govt. RSRM Lying in Hospital, Stanley Medical College 
,Chennai ,under the guidance and supervision of  Professor and Head Of the 
Department Dr.K.Kalaivani MD.,DGO., The dissertation is submitted to 
Tamilnadu Dr. M.G.R. Medical University, towards partial fulfillment of 
university rules and regulations for the award of M.S. Degree (Branch – II) in 
Obstetrics & Gynecology. 
 
 
 
Place : Chennai. 
Date : 
                                                                      Dr. KIRITHA RANJANI.A.C, 
                                                                                  
 
 
 
  


Submission author:
Assignment t it le:
Submission tit le:
File name:
File size:
Page count:
Word count:
Character count:
Submission date:
Submission ID:
Digital Receipt
This receipt acknowledges that Turnit in received your paper. Below you will f ind the receipt
inf ormation regarding your submission.
The f irst page of  your submissions is displayed below.
Kiritha Ranjani
2015-2015 plagiarism
thesis 1
THESIS_ORIGINAL.docx
1.05M
112
7,859
45,423
03-Oct-2016 02:22PM
710456588
Copyright 2016 Turnitin. All rights reserved.
ACKNOWLEDGEMENT 
I express my heartful gratitude to the Dean, Prof. Dr. ISSAC 
CHRISTIAN MOSES, M.D., FICP FACP., DEAN, Stanley Medical 
College ,Chennai-600001, for permitting me to conduct this study and use the 
facilities of the Instituition for my study. 
I am extremely thankful to my guide, Professor and Head of the 
Department, Dr. K. Kalaivani, MD., DGO., Govt. RSRM Lying in Hospital, 
Chennai-600001 for her support in conducting this study. 
I wish to express my deep sense of gratitude to my Co-guide  
Dr. Anuradha MD., OG., Assistant Professor, Govt. RSRM Lying in 
Hospital, Chennai, for her valuable guidance and precise suggestions at every 
stage of this study. 
I would like to express my sincere gratitude to Professor and Head Of 
The Department of Radiology, Dr. Amarnath MD, Govt. Stanley Medical 
College, Chennai,  to make use of  MRI reports for my study.                  
I express my sincere thanks to all the Members of the Institutional 
Ethical Committee  for giving approval for my study. 
I would like to  thank  Dr. Mr. Ravanan M.Sc., M.Phil., Ph.D., for 
helping in data analysis of my study. 
I also thank all the patients who were part of the study and my 
Professional colleagues for their support and criticisms. 
 
   
SL.N0. CONTENTS PAGE.N0. 
1.  INTRODUCTION  1 
2. AIM AND OBJECTIVES  3 
3. REVIEW OF LITERATURE  4 
4. MATERIALS AND METHODS  26 
5. METHODOLOGY 27 
5. DATA ANALYSIS AND RESULTS 29 
6. DISCUSSION  86 
7. SUMMARY 94 
8. CONCLUSION  96 
9. BIBLIOGRAPHY   
10. APPENDICES   
1 
 
INTRODUCTION 
Hypertensive disorders are one of the most common complications 
of pregnancy. 
It is one of the major cause of maternal and perinatal mortality and 
morbidity worldwide .Among the Hypertension disorders, Preeclampsia 
and Eclampsia are a life threatening multisystem disorder, which affects 
Cardiovascular, Hematological, Renal, Hepatic, and Central nervous 
system. 
        Cerebrovascular involvement is the direct cause of       death in 40% 
of the Gestational Hypertension patients. When it is diagnosed and 
intervened at the earlier, symptoms and radiological changes can be 
reversed. 
            Besides clinical presentation, Neuroimaging is the only route to 
find out the CNS involvement.  It provides a more accurate assessment of 
degree of CNS involvement. 
         Vascular pathology in the organs, is the main stay of subject of this 
study. Understanding the effect of Pregnancy and Postpartum state 
altering the structure and function of cerebrovascular system gives an 
important clue about emergence of Eclampsia. 
          Neurovascular changes and complication occurring as a result of 
vascular pathology in cerebrovascular system is the reason behind 
Eclampsia. When it is identified by imaging studies and intervened, we 
can prevent the complication becoming irreversible. 
           To identify the prevalence of neurovascular complications and 
neurovascular changes in Eclampsia, a prospective and retrospective 
analytical study was conducted in Government RSRM Lying in 
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hospital,Stanley Medical College, Chennai. MRI Brain was done for 50 
patients of Eclampsia and the findings were analysed.  
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AIM OF THE STUDY 
    
                Analytical study of MRI BRAIN in Antepartum and 
Postpartum Eclampsia patients. 
                   
                   To do MRI BRAIN for all Antepartum and Postpartum 
Eclampsia patients and to identify the cause ,to arrive at a proper 
diagnosis and further management. 
 
                  To intervene as soon as the cause is made to avoid maternal 
morbidity and mortality.  
 
                  To identify the prevalence of neurovascular complications in 
these cases. 
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REVIEW OF LITERATURE 
            Hypertension is one of the dreaded complication, resulting in 
Maternal, Fetal morbidity and mortality. It is a multiorgan failure mainly 
affecting cerebrovascular system endangering the life of the patient. 
            Pregnancy is related with cardiovascular adaptation according to 
the needs of mother and baby,both in systemic and local circulation.The 
changes in cerebral blood flow autoregulation and cerebrovascular 
resistance increases the permeability of BLOOD BRAIN 
BARRIER(BBB), resulting in hydrostatic edema. 
DEFINITION 
     Eclampsia, which is considered as a complication of severe 
Preeclampsia ,is defined as ,New onset of grand mal seizure activity 
And/or unexplained coma during pregnancy or postpartum in a woman 
with signs or symptoms of preeclampsia. 
      It typically occurs during or after the 20th week of gestation or in the 
postpartum period. 
      Preeclampsia is defined as Hypertension associated with Proteinuria, 
where hypertension is defined as a blood pressure of  140mmHg systolic 
or more and diastolic of 90mmHg or more, measured 6 hrs apart with 
proteinuria of more than 300mg/24hrs or  >1+ on dipstick (30mg/dl or 
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more) after 20 weeks of pregnancy in a previously normotensive and non 
proteinuric woman. 
CLASSIFICATION  
NATIONAL HIGH BLOOD PRESSURE EDUCATION PROGRAM 
WORKING GROUP (2000) 
GESTATIONAL HYPERTENSION  
1) BP >/= 140/90 mmHg for first time during pregnancy.   
2) No proteinuria.   
3) BP returns to normal < 12 weeks postpartum.   
4) Final diagnosis made postpartum.   
5) May have other signs and symptoms of pre-eclampsia  
for example, epigastric discomfort or thrombocytopenia.   
PRE-ECLAMPSIA 
Minimum criteria: 
BP >/= 140/90mm of Hg after 20 weeks gestation.   
Proteinuria>/=300mg/ 24 hours or >/= 1+ dipstick  
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Increased certainity of Pre-eclampsia:  
BP >/= 160/100mm of Hg  
Proteinuria 2gm/24 hours or 2+ dipstick.   
Serum creatinine > 1.2mg/dl unless known to be previously elevated.   
Platelets < 1,00,000/mm3  
Microangiopathic hemolysis (increased LDH)  
Elevated ALT or AST  
Persistent headache or other cerebral or visual disturbances.   
Persistent epigastric pain.   
 
ECLAMPSIA  
Seizures that cannot be attributed to other causes in a woman  
with pre-eclampsia.   
SUPER IMPOSED PRE-ECLAMPSIA  (ON CHRONIC 
HYPERTENSION)  
New onset proteinuria >/=300mg/24 hrs in a known hypertensive  
women without proteinuria occuring before 20 weeks of gestation.   
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Sudden increase in proteinuria or blood pressure or  
platelet count <1,00,000/mm3 in women with  
hypertension and proteinuria before 20 weeks gestation.   
 
CHRONIC HYPERTENSION  
BP > 140/90 mm Hg before pregnancy or diagnosed  
before 20 wks gestation not attributable to gestational  
trophoblastic disease.   
                                                    Or  
Hypertension first diagnosed after 20 weeks gestation  
and persistent after 12 weeks postpartum. 
 
PROTEINURIA 
      Proteinuria is an important sign of preeclampsia.It helps in assessing 
the severity of preeclampsia.The mechanism behind proteinuria is 
vasospasm of afferent glomerular arterioles leading to anoxic damage to 
endothelium of glomerular tuft resulting in endotheliosis. It will result in 
increased capillary permeability causing leakage of proteins, tubular 
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reabsorption is equally depressed. Significant proteinuria is described as 
300mg/l or more of urinary protein loss in 24 hours or persistent 30mg/dl 
(1+ dipstick) in random clean catch sample on atleast 2 occasions 
collected 6 hours apart. Dipstick method is routinely used to measure 
proteinuria and colour changes indicates 
PROTEIN  
Trace  -    0.1gm/l 
1+          -      0.3gm/l 
2+          -      1.0gm/l 
3+          -      3.0gm/l 
4+          -      10gm/l 
INCIDENCE 
The incidence of preeclampsia is 7-10% depending on the 
population studied. The incidence of eclampsia in Govt RSRM Lying in 
Hospital, Chennai is 0.5% Worldwide approximately 50,000 women are 
estimated to die annually because of eclampsia.The overall maternal 
death rate of eclampsia is 2% . 
               The perinatal mortality among babies born to eclamptic  mother 
was 32% compared to 10.5% for Total perinatal mortality.  
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PATHOPHYSIOLOGY 
   The underlying basic pathology in Eclampsia & Pre eclampsia is 
endothelial dysfunction and intense vasospasm affecting almost all 
vessels particularly Uterus, Kidney, Placental bed and Brain. 
There is increase in circulatory pressor substances and increased 
sensitivity of vascular system to normally circulating pressor substances. 
         Normally there is an invasion of endovascular trophoblasts into 
walls of spiral arterioles of uteroplacental bed. In first trimester, 
endovascular trophoblasts invades upto decidual segments.In second 
trimester it invades upto myometrial segments. This process replaces 
endothelial lining and muscular wall by fibrinoid formation, finally spiral 
arterioles becomes distended, tortuous and funnel shaped. Thus spiral 
arterioles changes into low resistance low pressure high flow system. 
In Preeclampsia, there is a failure of second wave of endovascular 
trophoblast migration and there is reduction of blood supply to 
fetoplacental unit. 
In Preeclampsia there is imbalance in different components of 
prostaglandins, relative or absolute deficiency of vasodilator,PGI2 from 
vascular endothelium, and increased synthesis of thromboxane, a potent 
vasoconstrictor of platelets. 
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       Increased vascular sensitivity to Angiotensin II and also 
Angiotensinase activity is depressed due to proteinuria with elimination 
of alpha 2 globulins. 
Nitric oxide is synthesized from L-arginine from vascular 
endothelium and syncytiotrophoblast, which helps in vasodilation and 
anti platelet aggregation. It prevents intervillous thrombosis. Deficiency 
of Nitric oxide contributes to hypertension. 
Endothelin-1 is synthesized by endothelial cells and is a potent 
vasoconstrictor contributing to the cause of hypertension. 
Cytokines, Interleukins are derived from activated leukocytes 
leading to endothelial injury. 
Abnormal lipid metabolism results in oxidative stress. Lipid 
peroxides, ROS, and superoxide radicals cause endothelial injury and 
dysfunction. 
Factor V leiden mutation is one of the cause. 
Immunological response of mother to increased circulating levels 
of VCAM-1 resulting in the formation of immune complexes in placenta, 
maternal serum and other organs. 
  Extravillous trophoblasts expressing reduced amounts of 
nonclassic HLA G are prone to become preeclamptic.  
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        In case of T helper cells ,Th1 action is increased and Th1/Th2 ratio 
changes which leads to enhanced immunologically mediated 
inflammatory reaction, triggered by placental microparticles and 
adipocytes. 
Polymorphisms of genes for Fas receptor, hypoxia inducible factor 
-1 alpha protein (HIF-1α) Protein,IL-1β,Lymphotoxin-α,TGF-β3, apoE, 
are associated with preeclampsia. 
Circulating endothelial cells and circulating microparticles 
(CEC,CMP) are elevated fourfold in preeclamptic women. 
Increased serum levels of soluble endoglins and Soluble Fms-like 
tyrosinase kinase 1(sFlt-1) which are antiangiogenic disrupt endothelial 
function and release inflammatory mediators resulting in preeclampsia. 
John and colleagues (2002) showed in general population, a diet 
high in fruits and vegetables  that is having antioxidant activity decreases 
blood pressure. 
       Coagulation abnormalities is due to increased activation & 
consumption of platelets & low antithrombin III levels, abnormal 
prostaglandins metabolism & in few cases florid DIC.  
These changes lead to hypertension, edema,proteinuria, bleeding 
tendency, renal dysfunction, liver damage & neurological abnormalities.  
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CEREBROVASCULAR PATHOPHYSIOLOGY: 
                  The Brain is protected from extremes of blood pressure by an 
autoregulation system that ensures constant perfusion, over a range of 
systemic pressure, in response to systemic hypotension, cerebral 
arterioles dilates to maintain perfusion. Above the limits of auto 
regulation, hypertensive encephalopathy may occur. 
                  The classic microvascular lesion is fibrinoid necrosis of the 
arterial wall, perivascular microinfarcts, and hemorrhages. Major lesions 
are subcortical edema, multiple non hemmorhagic areas of softening in 
the entire brain and hemmorhagic areas in white matter. 
                   The hemorrhages are also seen in pons and basal ganglia 
which may rupture into ventricles. 
              First theory, Trommer (1988) proposed that in response to acute 
and severe hypertension, cerebrovascular overregulation leads to 
vasospasm. Resulting hypoxia leads to ischaemia and CYTOTOXIC 
EDEMA. 
                     Second theory, when the systemic blood pressure rises 
above the cerebral autoregulatory pressure forced dilation and 
vasoconstriction of vessels takes place. At capillary level, it disrupts end-
capillary pressure causing increased hydrostatic pressure, hyperperfusion, 
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and extravasation of plasma and red cells through endothelial tight 
junction openings, leading to VASOGENIC EDEMA. 
                    Hinchey (1996) ,with imaging studies,these changes present 
as Posterior reversible leukoencephalopathy syndrome. 
                     Cipolla(2014),proposes that PRES is most common in 
parietooccipital cortex,boundary zone of anterior, middle and posterior 
cerebral arteries. In most situations,these lesions aree reversible. 
Recent hypothesis suggests that syndrome results from 
breakthrough of autoregulation with passive overdistension of cerebral 
arterioles.It would result in interstitial extravasation of protein and fluid 
causing focal vasogenic (hydrostatic edema) in peripheral vascular 
distribution of involved vessel. 
In eclampsia, presumably due to loss of autoregulation of cerebral  
blood flow, there was hyperperfusion similar to hypertensive 
encephalopathy, women with headache have increased cerebral perfusion. 
          Apollon and co-workers 2000, Cunningham and Twickler 2000  
Concluded that Eclampsia is due to transient loss of cerebral 
autoregulation resulting in widespread hypodense areas confirmed by 
MRI. 
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            Zeeman et al found in normal pregnancy cerebral blood flow  
decreases early in pregnancy and is 20 percent less than  non pregnant 
value in late pregnancy. Their investigations showed that preeclampsia 
,there is hyperperfusion leading to vasogenic edema which is identified 
using MRI.                
            The regional heterogeneity of sympathetic vascular  innervations 
explains the susceptibility of posterior circulation in pathology. 
                Experimental studies proposed that sympathetic innervation of 
the intracranial arterioles is shown to protect the brain from  marked 
blood pressure. Ultrastructural studies shows that Internal carotid system 
is much better supplied with sympathetic  innervations than in 
Vertebrobasilar system.                
                         Posterior circulation is mostly affected because 
perivascular sympathetic nerves protect anterior circulation but not the 
posterior.                      
                           Preeclampsia is termed as “TOXEMIA OF 
PREGNANCY” presents with various histologic features. During 
autopsy, these findings are usually made out. 
                            There are two types of pathology seen in brain as a 
result of eclampsia. 
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GROSS HEMMORHAGE: 
Severe hypertension causing rupture of arteries resulting in gross 
hemorrhage. 
FOCAL LESIONS: 
                     Sometimes it presents with more widespread, focal and 
seldom fatal lesion. They are edema, hyperemia, ischaemia, thrombosis 
and  hemorrhage. 
                      As cerebral hypoperfusion mostly affects parietal and 
occipital lobes, headache and stomata usually presents. 
                     Sibai(2005) and Zwart(2008), 50-75% of women present 
with headaches,20-30% presents with visual changes preceding eclamptic 
convulsions. intensity of headache varies from mild ,severe, intermittent 
to constant, which usually does not respond to analgesia but responds to 
Magnesium sulfate regime. 
                      Meldrum (2002), convulsions are caused by excessive 
release of glutamate which causes massive depolarization of network 
neurons, and bursts of action potentials causing extended seizures 
resulting in brain injury . 
                    (Cunningham,1995) states that blindness is rare with 
preeclampsia alone, but it complicates eclampsia in 15%of women. 
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                     Blindness manifests about a week or more after delivery 
(chamber,2004) 
 Final and worse presentation is GENERALISED CEREBRAL 
EDEMA, which present with mental status changes, varying from 
confusion to coma. The most dreaded complication of this is Tentorial  
Herniation.            
Various imaging modalities are available to diagnose the lesion. 
? MRI of Brain 
? CT 
? MR ANGIOGRAPHY 
? TRANSCRANIAL DOPPLER STUDY 
? SPECT 
 
MRI OF BRAIN: 
                 Magnetic Resonance Imaging (MRI) is well known for its far 
more superior soft tissue contrast and multiplanar resolution when it is 
compared to CT scan. It is good at diagnosing hemorrhage, ischaemia and 
edema.  
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       In case of cerebaral edema usually CT reports normal study. When in 
case of MRI it demonstrates transient T2 lesions in suncortical regions of 
parieto occipital lobes. 
Brainstem and/or basal ganglia which are rarely involved is also 
diagnosed with MRI. 
        Raps 1993 and Bartynski 2003, proposed that, In case of late 
postpartum eclampsia, CT usually shows low density reas. But in MRI it 
shows positive T2 MRI .  
        Morriss et al found that minimal changes are found on T2 MRI in 
2/10 of severely preeclamptic women based on increased signal intensity 
compared to abnormal findings in T2 signal intensity in women with 
eclampsia. these patients present with symptoms of headache, vertigo, or 
visual disturbances. 
At times persistent hyperintense T2 lesions actually represent 
permanent brain lesions consistent with infarctions. 
Diffuse Weighted Magnetic Resonance Imaging and Apparent 
Diffusion Coefficient  mapping (DWI/ADC)  
Two different types of cerebral edema, vasogenic and cytotoxic are 
differentiated by using neuroimaging techniques. Vasogenic edema is due 
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to increased hydrostatic pressure and capillary leak. Cytotoxic edema  
usually presents with cell death. 
                       It is impossible to differentiate between these forms 
between CT and MRI techniques. With series of MR  acquisitions, 
Diffusion Weighted Imaging Sequences and Apparent 
  Diffusion coefficient maping, it is possible nowadays to 
characterize T2 MRI images with hyperintensity in eclamptic women 
using (DWI/ADC) 
                        DWI technique works on the principle of Quantification of 
diffusion of free water, which is found to be decreased in ischaemic brain 
tissue .Thus ischaemic brain regions can be identified within minutes to 
hours after onset of neurological symptoms. This appears as area of high 
signal intensity compared with signal from normal brain. After an 
ischaemic event evaluation, there is a shift of water from extracellular to 
Intracellular space which results in restricted diffusion and therefore 
reduced ADC values. 
                       It mainly results from decreased Na+ K+ ATP ase activity 
in the glial cell membranes and therefore results in decrease in water 
molecule transporting causing cell death. These areas represents cytotoxic 
edema and or visualized as hyperintense lesions on DWI. Thus regional 
ADC values is an important noninvasive tool for  monitoring the 
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evaluation of time and to identify spatial expansion of the ischaemic 
lesions.                        
                        Reversible vasogenic edema can be identified by a 
combination of normal DWI with high T2 signal lesions and increased 
ADC.                    
                    Studies using additional diffusion weighted imaging 
sequences found the origin of brain edema is mainly vasogenic but can be 
ischaemic or cytotoxic in an eclamptic patients. In such cases, DWI 
hyperintense lesions with decreased ADC is present in a case of 
vasogenic edema.               
                   Characteristic findings in MRI of Brain are hyperintense 
lesions on T2 weighted, Fluid Attenuation Inversion Recovery (FLAIR) 
Or proton weighted sequences which usually affects the grey and white 
matter of occipital or parietal lobes. 
                    Other areas affected are deep white matter structures, basal 
ganglia and white matter of frontal or temporal lobes and brain stem.                
                    Louiero 2003, Zeeman 2004 explained advantage of taking 
MRI in eclampsia patients. It appears that 20-25 % of women with 
eclampsia explains the lesions are consistent to be cerebral infarction 
(Sheehan 1973, Richards 1988). It has to be mentioned that all these 
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women were normotensive as well as asymptomatic at time of the follow 
up.  
                       Longstreth 1996, Bernick found that, Subclinical infarcts 
and white matter lesions in general are associated with an increased risk 
of clinical stroke events, physical limitations and cognitive impairment 
such as dementia. 
                         Trommer 1988, Lewis 1988, Will 1987  proposed that 
vasospasm presents in MRA as diffuse or multifocal segmental 
narrowings or vasospasm of the cerebral vasculature. 
                       Kanayama 1993, Ito 1995, instead of intracranial 
hemorrhage, vasospasm may be the only finding in eclampsia which may 
be persistent upto two weeks postpartum. 
                        Recent experiments found out that vasospasm appears as 
sausage string pattern in angiography. 
                         In few eclamptic women, sudden death occurs 
concurrently with convulsions or shortly after convulsions.It happens 
mostly in case of massive cerebral hemorrhage. 
                        Older women with chronic hypertension presents with 
cerebral hemorrhage due to long standing  hypertension induced 
lipohyalinosis of small and medium sized arteries. In that case 
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striatocapsular area, thalamus, cerebellum and brain stem are the sites 
most frequently affected, Imaizumi 2004.  
                    Alternatively, Salerni et al 1988 describes that cerebral 
infarction may transform into a hemorrhagic infarction in case of young 
nulliparae  presenting with HELLP syndrome. 
                    Another rare cause of intracerebral hemorrhage is rupture of 
aneurysm or arteriovenous malformation.  
                    In subrachnoid hemorrhage  a small amount of blood is seen 
over the convexity of the frontal/parietal lobes extending into the sylvian 
fissure or interhemispheric tissue.              
                     With Conventional angiography  ,ruptured arterio venous 
malformation or intracranial aneurysm, or cortical venous sinus 
thrombosis can be made out. 
                      Shah 2003, Gregory 2003, proposed that Subarachnoid 
hemorrhage in eclampsia is the result of rupture of cortical petechiae over 
the surface of the brain or rupture of small pial veins. This type of 
subarachnoid hemorrhage seems to carry a benign prognosis. 
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                        Giannina describes a subdural hematoma associated with 
thrombocytopenia in an eclamptic women ,which spontaneously 
developed. Uncal herniation is an another cause of death of the patient. 
                         Biller 1995 found out that in an eclamptic patient with 
hematoma in right basal ganglia  which transformed into an abscess due 
to secondary infection of episiotomy through bacterial dissemination. 
PRES 
           POSTERIOR REVERSIBLE ENCEPHALOPATHY 
SYNDROME (PRES) also known as REVERSIBLE POSTERIOR 
LEUCOENCEPHALOPATHY SYNDROME (RPLS) is hypothesized 
to be the primary injury based on its clinical pathological as well as 
neuroimaging features. In non pregnant patients PRES may occur after a 
subacute elevation of blood pressure. Areas of cerebrovascular 
vasodilation and vasoconstriction may both coexist in the acute phase of 
hypertension. The clinical presentation is variable and may include 
headache, seizures, visual changes, altered mental status and occasionally 
focal neurological signs. 
PATHOLOGY: 
 The endothelial cell dysfunction is thought to play a dominant role 
in the pathogenesis of PRES. Endothelial injury leading to altered 
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regulation of cerebrovascular response for the release of systemic 
vasoactive metabolites like AT II as well as to the release of Endothelial 
vasoactive substances resulting in hyper activity of blood vessels and 
labile blood pressure.  
 MRI findings include hyperintensities on T2 weighted images. 
Three patterns described on MRI imaging include, superior frontal sulcus 
pattern, Dominant parieto-occipital pattern and Holo hemispheric 
watershed pattern.  
 Treatment is based on the cause. Control of blood pressure may 
alleviate the symptoms. Many cases will resolve within one to two weeks 
of controlling the blood pressure and eliminating the triggering factors. 
Yet uncommon death may occur due to intracerebral hemorrhage or 
cerebral edema. PRES may occur in 5-10% of cases.  
Optic Changes in Eclamptic Patients 
          Visual disturbances are seen in 40% of eclampsia 
patients. They include scotomota, amaurosis, blurred vision, diplopia, 
chromatopsia or homonymous hemianopsia (Weiner 1987). The 
pathology behind the visual disturbance / blindness is retinal edema and 
vascular changes such as retinal arteriolar vasospasm or thrombosis of the 
central retinal artery or retinal detachment.  
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                         Moseman 2002 stated that with newer MRI imaging 
modality ,lateral geniculate body edema along with focal cerebral edema 
can be made out.These features lead to cortical blindness. 
 Cortical blindness  
              Cortical blindness  presents with intact pupillary light reflexes 
,intact ocular movements and normal ophthalmologic findings which 
excludes the peripheral cause of blindness. 
               Transient blindness  is calculated to  occur in about 1-15 % 
(Cunningam 1995, Torres 1995) in eclampsia patients. This is seen in 
MRI as T2 hyperintense lesions . 
                Lesions are seen particularly in the parieto-occipital area which 
are supplied by the posterior circulation, and are reversible in follow up 
imaging studies. 
                It is usually confirmed by diffusion MRI which shows the 
absence of restricted diffusion in the presene of vasogenic edema. 
              So far, only three women have been described in the literature 
demonstrating permanent blindness. Two of them had a combination of 
both abnormal retinal findings consistent with Purtschers retinopathy and 
MR evidence of brain infarcts located in the lateral geniculate nuclei 
Blodi 1990, Moseman 2002.The third patient with persistent blindness 
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did not undergo MR imaging and therefore no conclusions can be drawn, 
Lara 2002. Two additional case reports deserve mention. Delefosse 
describes a case of transient cortical blindness in a woman who was 26 
days postpartum. The authors concluded that retained placental fragments 
may be associated Delefosse 2003. 
Finsterer describes a preeclamptic patient who suffered transient 
cortical blindness after nitroglycerin administration. MR imaging with 
diffusion sequences demonstrated a typical picture of vasogenic edema. 
The authors conclude that nitroglycerin may aggravate the development 
of vasogenic edema secondary to enhancement of cerebrovascular 
vasodilation and may result in cortical blindness 
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MATERIALS AND METHODS 
 
TYPE OF STUDY 
 Prospective and Retrospective Analytical study. 
  
PERIOD OF STUDY 
 September 2014 to August 2016 
 
SETTING 
 The study was conducted at Govt. Stanley medical college. 
The study was approved by the board of ethical committee. 
 
SAMPLE SIZE 
 50 
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METHODOLOGY 
 
SCREENING 
                  MRI Brain is done for all antepartum and postpartum 
eclampsia patients after stabilising them. 
 
PROSPECTIVE STUDY 
                After getting consent ,MRI Brain is done for all antepartum and 
postpartum eclampsia patients and the findings are analysed. 
 
                Duration: Jan 2016 - August 2016. 
 
RETROSPECTIVE STUDY 
                Case sheets and MRI Brain reports of all antepartum and 
postpartum eclampsia patients are taken from MRD after obtaining 
permission from Superintendent and MRD incharge. 
                Duration: Sep 2014-Dec 2015. 
 
INCLUSION CRITERIA 
Antepartum eclampsia  
Postpartum eclampsia  
 
EXCLUSION CRITERIA 
Epilepsy 
Cerebral tumours 
Preexisting renal disorders. 
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CONSENT  
 
 Informed consent in the form of written consent was obtained from 
the patients or relatives (in situations where patients is indisposed) after 
explaining the procedure. 
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DATA ANALYSIS AND RESULTS 
 
 MRI Brain was taken for 50 patients with Eclampsia .MRI findings 
and data collected from the 50 patients are analysed. 
 
AGE IN YEARS 
 
TABLE-1: AGE DISTRIBUTION 
 
Age in years 
 
Frequency 
 
Percent 
 
18-20 12 24.0 
21-25 29 58.0 
26-35 9 18.0 
TOTAL 50 100.0 
 
 
 
 
 
 
 
 
 
 
 
The most common age group in our study is in the range of 21-25 
yrs. 29% of the patients were in the range of 21-25 yrs. Only 9% of the 
patients were in the age group of more than 25 years. 
 
Age in years
26-35
21-25
18-20
30 
 
AGE IN YEARS * MRI Finding 
 
  
 
Age in years 
 
 
MRI Finding Total 
 
P value 
Normal Abnormal 
18-20 
  
  
Count 10 2 12  
 
 
 
 
 
 
 
 
0.543 
% within 
Age in years 83.3% 16.7% 100.0% 
% within 
MRI Finding 25.0% 20.0% 24.0% 
21-25 
  
  
Count 24 5 29 
% within 
Age in years 82.8% 17.2% 100.0% 
% within 
MRI Finding 60.0% 50.0% 58.0% 
26-35 
  
  
Count 6 3 9 
% within 
Age in years 66.7% 33.3% 100.0% 
% within 
MRI Finding 15.0% 30.0% 18.0% 
 
 
50% of the patients having abnormal MRI finding falls under the age 
group of 21-25 yrs, which is statistically not significant (p value is 0.543). 
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PARITY 
 
TABLE-2: PARITY 
 
Parity 
 
 
Frequency 
 
 
Percent 
 
 
Primi 
20 40.0 
Multi 
30 60.0 
Total 
50 100.0 
 
 
 Multigravida constitutes the majority in our study.60% of the 
patients were multigravida. 
 
Parity
Multi
Primi
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                     PARITY* MRI FINDING 
 
 
 
In my study group , 80% of the patients who have abnormal MRI 
findings were Multipara which is not statistically significant (p value 
0.139) 
 
  
Parity 
 MRI Finding P value 
 Normal Abnormal  
 Primi Count 18 2  
  % within 
Parity 
90.0% 10.0% 
 
   % within 
MRI 
Finding 
45.0% 20.0% 
 
 
 
         0.139  Multi Count 22 8 
  % within 
Parity 
73.3% 26.7% 
  % within 
MRI 
Finding 
55.0% 80.0% 
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BODY MASS INDEX 
 
TABLE-3: BODY MASS INDEX 
 
BODY MASS INDEX 
 
Frequency 
 
Percent 
 
Normal 27 54.0 
Over weight 16 32.0 
Obese 7 14.0 
Total 50 100.0 
                                       
 
In my study group,54% of the patients have normal BMI.14 % of the 
patients are obese. 
 
BMI
Obese
Over weight
Normal
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                                BMI * MRI Finding 
 
  
 
    
MRI Finding 
P value Normal 
Abnorma
l 
 
 
 
 
 
 
Normal Count 18 9 
.036* 
% within 
BMI 66.7% 33.3% 
% within 
MRI 
Finding 
45.0% 90.0% 
Over weight Count 15 1 
% within 
BMI 93.8% 6.3% 
% within 
MRI 
Finding 
37.5% 10.0% 
Obese Count 7 0 
% within 
BMI 100.0% .0% 
% within 
MRI 
Finding 
17.5% .0% 
 
 
90% of the normal BMI patients  have abnormal MRI findings. 
p value 0.036* which is statistically significant. 
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GESTATIONAL AGE (in weeks) 
   
 
TABLE-4: GESTATIONAL AGE 
 
GA in weeks 
 
Frequency 
 
Percent 
 
  20-28 4 8.0 
  29-36 25 50.0 
  37-40 11 22.0 
  Postpartum 10 20.0 
  Total 50 100.0 
 
 
Most of the patients were in the antenatal period in my study group 
at the time of presentation In my study group 50% percent of the patients 
falls between 29-36 weeks of gestational age.10% are postpartum 
patients. 
GA in weeks
Postpartum
37-40
29-36
20-28
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GESTATIONAL AGE IN WEEKS * MRI FINDING  
 
    MRI Finding  
P value    Normal Abnormal 
GA in weeks 20-28 Weeks Count 1 3  
 
 
 
 
 
 
 
 
.003** 
    % within GA 
in weeks 
25.0% 75.0% 
    % within MRI 
Finding 
2.5% 30.0% 
  29-36 Weeks Count 22 3 
    % within GA 
in weeks 
88.0% 12.0% 
    % within MRI 
Finding 
55.0% 30.0% 
  37-40 Weeks Count 11 0 
    % within GA 
in weeks 
100.0% .0% 
    % within MRI 
Finding 
27.5% .0% 
  Postpartum Count 6 4 
    % within GA 
in weeks 
60.0% 40.0% 
    % within MRI 
Finding 
15.0% 40.0% 
 
In our study group, the gestational age between 20-28 weeks  and 
29-36 weeks have 30% of abnormal MRI findings each. But in the 
postpartum group, 40% of the patients have abnormal MRI findings. p 
value is 0.003, Significant. 
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DURATION OF HYPERTENSION SINCE DIAGNOSIS 
 
TABLE-5: DURATION OF HYPERTENSION SINCE DIAGNOSIS 
 
 
Frequency 
 
Percent 
 
At presentation 
21 52.5 
1-4 Weeks 
18 45.0 
> 4 Weeks 
1 2.5 
Total 
40 100.0 
 
 
 
 In our study, 52.5% of the patients with eclampsia had 
hypertension diagnosed only at the time of presentation. Only 2.5% of the 
patients has hypertension for more than 4 weeks. Rest of the 10% patients 
are postpartum. 
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Duration in weeks
Postpartum
> 4 
1-4
At presentation
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 DURATION IN WEEKS*MRI FINDING 
 
    
MRI Finding 
P value Normal
Abnor
mal 
Duration in 
weeks 
At 
presentation
Count 19 2 
.495 
% within 
Duration in 
weeks 
90.5% 9.5% 
% within 
MRI 
Finding 
55.9% 33.3% 
1-4 Count 14 4 
% within 
Duration in 
weeks 
77.8% 22.2% 
% within 
MRI 
Finding 
41.2% 66.7% 
> 4 Count 1 0 
% within 
Duration in 
weeks 
100.0% .0% 
% within 
MRI 
Finding 
2.9% .0% 
 
 
 
 Patients who presented with Eclampsia, 1-4 weeks after the onset 
of hypertension have abnormal MRI finding of 66.7%, p value is 0.495, 
not significant. 
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PROTEINURIA 
 
 
TABLE-6: URINE ALBUMIN 
 
URINE ALBUMIN Frequency Percent 
  1+ 6 12 
  2+ 21 42.0 
  3+ 6 12.0 
  Total 50 100.0 
 
 
 
Urin Albumin
3+
2+
1+
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PROTEINURIA * MRI FINDING 
 
    MRI Finding  
P value     Normal Abnormal 
Urin 
Albumin 
1+ Count 19 4  
 
 
 
 
 
 
 
.678 
    % within 
Urin 
Albumin 
82.6% 17.4% 
    % within 
MRI 
Finding 
47.5% 40.0% 
  2+ Count 17 4 
    % within 
Urin 
Albumin 
81.0% 19.0% 
    % within 
MRI 
Finding 
42.5% 40.0% 
  3+ Count 4 2 
    % within 
Urin 
Albumin 
66.7% 33.3% 
    % within 
MRI 
Finding 
10.0% 20.0% 
 
 
In our study group (table 6), 47.5% of the patients with normal 
MRI findings and 40% of the patients with abnormal MRI findings have 
proteinuria of 1+. p value is 0.678 which is statistically not significant. 
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IMMINENT SYMPTOMS 
 
 
 
TABLE -7 : IMMINENT SYMPTOMS 
 
  Frequency Percent 
  Present 45 90.0 
  Absent 5 10.0 
  Total 50 100.0 
 
In our study group, 90% of the patients have imminent symptoms, 
10% have no imminent symptoms. 
 
 
Imminent Symptoms
Absent
Present
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                  IMMINENT SYMPTOMS* MRI FINDING 
 
 
    
MRI Finding 
P value Normal
Abnor
mal 
Imminent 
Symptoms 
Present Count 35 10  
% within 
Imminent 
Symptoms 
77.8% 22.2%  
% within 
MRI Finding 87.5% 100.0%  
Absent Count 5 0  
% within 
Imminent 
Symptoms 
100.0% .0% 0.239 
% within 
MRI Finding 12.5% .0%  
     
    
    
 
 
 In our study group, 22.2% of the patients with Imminent symptoms 
have 100% of abnomal MRI finding. Remaining 77.8% with Imminent 
symptoms have 87.5% Normal MRI findings. p value = 0.239, which is 
statistically not significant.  
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SEIZURE 
Table-8: SEIZURE 
 
  Frequency Percent 
  Positive 
 
 
50 100.0 
 
In our study group, all patients had seizures. 
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Seizure
Positive
 
 
 
 
 
                                             SEIZURE*MRI FINDING 
  
    MRI Finding 
    Normal
Abnor
mal 
Seizure Positive Count 40 10 
    % within 
Seizure 80.0% 20.0% 
    % within 
MRI 
Finding 
100.0% 100.0% 
    
   
   
 
 
Only 10% of the Eclampsia patients have abnormal MRI findings. 
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PAST HISTORY 
 
Table-9: PAST HISTORY 
 
 
FREQUENCY
 
PERCENT 
 
  No 50 100.0 
 
In our study all Eclampsia patients do not have significant past history. 
 
 
Past History
No
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CONSCIOUS LEVEL 
 
Table-10: CONSCIOUS LEVEL 
 
  
FREQUENCY 
 
PERCENT 
 
  Conscious 29 58.0 
  Drowsy 13 26.0 
  Unconscious 8 16.0 
  Total 50 100.0 
       
Among the patients presenting with Eclampsia, 29 patients were 
conscious,13 were drowsy and only 8 were unconscious.                
Conscious level
Unconscious
Drowsy Conscious
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CONSCIOUS LEVEL * MRI FINDING 
 
  
    
MRI Finding 
P valueNormal
Abnor
mal 
Conscious 
level 
Conscious Count 28 1  
% within 
Conscious 
level 
96.6% 3.4%  
% within 
MRI 
Finding 
70.0% 10.0%  
Drowsy Count 9 4  
% within 
Conscious 
level 
69.2% 30.8% .001** 
% within 
MRI 
Finding 
22.5% 40.0%  
Unconscious Count 3 5  
% within 
Conscious 
level 
37.5% 62.5%  
% within 
MRI 
Finding 
7.5% 50.0%  
     
    
 
    
 
In the study group, 10% of conscious patients,30.8 % of drowsy 
patients, 50% of unconscious patients have abnormal MRI findings. p 
value is 0.001 ,which is statistically significant. 
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SYSTOLIC BLOOD PRESSURE 
 
Table-11: SBP 
 
  
Frequency 
 
Percent 
 
 < 140 1 2.0 
  140-160 33 66.0 
  161-200 16 32.0 
 Total 50 100.0 
     
Most of patients in our study group have systolic blood pressure in 
the range of 140-160 mmHg  .only 2%  have SBP of <140 mmHg. 
 
 
 
 
           
SBP
161-200
140-160
< 140
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SBP * MRI Finding 
 
    
MRI Finding 
P value Normal
Abnor
mal 
SBP < 140 Count 1 0  
% within 
SBP 100.0% .0%  
% within 
MRI 
Finding 
2.5% .0%  
140-160 Count 30 3  
% within 
SBP 90.9% 9.1%  
% within 
MRI 
Finding 
75.0% 30.0% .015** 
161-200 Count 9 7  
% within 
SBP 56.3% 43.8%  
% within 
MRI 
Finding 
22.5% 70.0%  
     
    
    
 
 
  
In the study group, 70% of the patients who have abnormal MRI 
findings have systolic blood pressure in the range of 161-200mmHg. (p 
value is 0.015**) which is statistically significant. 
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DIASTOLIC BLOOD PRESSURE 
   
 
TABLE-12: DBP 
 
  
Frequency 
 
Percent 
 
  90-100 17 34.0 
  101-110 9 18.0 
  > 110 24 48.0 
  Total 50 100.0 
 
Out of 50 patients in our study group, 48% patients have diastolic 
blood pressure of more than 110 mmHg. Only 18%  have diastolic blood 
pressure in the range of 101-110 mmHg. 
DBP
> 110
101-110
90-100
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   DBP * MRI FINDING 
 
  
    
MRI Finding 
P value Normal
Abnor
mal 
DBP 90-100 Count 13 4  
% within 
DBP 76.5% 23.5%  
% within 
MRI 
Finding 
32.5% 40.0%  
101-110 Count 8 1  
% within 
DBP 88.9% 11.1%  
% within 
MRI 
Finding 
20.0% 10.0% .746 
> 110 Count 19 5  
% within 
DBP 79.2% 20.8%  
% within 
MRI 
Finding 
47.5% 50.0%  
     
    
    
 
In my study group, 50% of patients with abnormal finding have 
diastolic blood pressure >110 mmHg.  p value is 0.746 which is not 
significant. 
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MEAN ARTERIAL PRESSURE 
 
 
Table-13: MEAN ARTERIAL PRESSURE 
 
  
Frequency 
 
Percent 
 
  96-116 8 16.0 
  116-126 9 18.0 
  > 126 33 66.0 
  Total 50 100.0 
 
In our study group, 33 patients have their mean arterial pressure 
>126, where only 8 people have mean arterial pressure in the range of 96-
116. 
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MAP
> 126
116-126
96-116
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MAP * MRI Finding 
 
    
MRI Finding 
P value Normal
Abnor
mal 
MAP 96-116 Count 7 1  
% within 
MAP 87.5% 12.5%  
% within 
MRI 
Finding 
17.5% 10.0%  
116-126 Count 8 1  
% within 
MAP 88.9% 11.1%  
% within 
MRI 
Finding 
20.0% 10.0% .578 
> 126 Count 25 8  
% within 
MAP 75.8% 24.2%  
% within 
MRI 
Finding 
62.5% 80.0%  
     
    
    
 
In my study group, 80% of the patients with abnormal MRI finding 
have Mean arterial pressure of >126 mmHg. p value is 0.578, not 
significant. 
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FUNDUS 
Table-14: FUNDUS 
 
  
Frequency 
 
Percent 
 
  Normal 48 96.0 
  Grade I 2 4.0 
  Total 50 100.0 
 
Out of 50 patients,48 patients have normal fundus. Only two 
Patients have hypertensive retinopathy of Grade I. 
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Fundus
Grade I
Normal
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FUNDUS * MRI FINDING 
 
    
MRI Finding 
P value Normal
Abnor
mal 
Fundus Normal Count 39 9  
% within 
Fundus 81.3% 18.8%  
% within 
MRI 
Finding 
97.5% 90.0%  
Grade I Count 1 1 .279 
% within 
Fundus 50.0% 50.0%  
% within 
MRI 
Finding 
2.5% 10.0%  
     
    
    
 
 
In our study group, 90% of the patients with abnormal MRI finding 
have normal fundus. 
 Fundus
Grade INormal
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HEMOGLOBIN 
TABLE-15: HEMOGLOBIN 
 
  
Frequency 
 
Percent 
 
  7-9 6 12.0 
  9-11 36 72.0 
  > 11 8 16.0 
  Total 50 100.0 
 
36 patients have Hb% in the range of 9-11g%.6 patients have 
hemoglobin ranging between 7-9 g%. 
Hemoglobin
> 11
9-11
7-9
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HEMOGLOBIN * MRI FINDING 
 
 
    
MRI Finding 
P value Normal
Abnor
mal 
Hemoglob
in 
7-9 Count 5 1  
% within 
Hemoglob
in 
83.3% 16.7%  
% within 
MRI 
Finding 
12.5% 10.0%  
9-11 Count 30 6  
% within 
Hemoglob
in 
83.3% 16.7%  
% within 
MRI 
Finding 
75.0% 60.0% .402 
> 11 Count 5 3  
% within 
Hemoglob
in 
62.5% 37.5%  
% within 
MRI 
Finding 
12.5% 30.0%  
     
    
    
 
In my study group,60% of the patients having abnormal MRI 
finding have hemoglobin in the range of 9-11g%.The patients with Hb in 
the range of 7-9 g% have only 10% of abnormal finding. p value is 0.402 
which is not statistically significant. 
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PLATELET COUNT IN LAKHS 
 
Table-16: PLATELET COUNT 
 
  
Frequency 
 
Percent 
 
  1-2 L 19 38.0 
  2-3 L 26 52.0 
  3-4 L 5 10.0 
  Total 50 100.0 
              
Platelet count in lakhs
3-4
2-3
1-2
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PLATELET COUNT IN LAKHS * MRI FINDING 
 
  
 
    
MRI Finding 
P value Normal
Abnor
mal 
Platelet 
count in 
lakhs 
1-2 Count 15 4  
% within 
Platelet 
count in 
lakhs 
78.9% 21.1%  
% within 
MRI 
Finding 
37.5% 40.0%  
2-3 Count 22 4  
% within 
Platelet 
count in 
lakhs 
84.6% 15.4% .447 
% within 
MRI 
Finding 
55.0% 40.0%  
3-4 Count 3 2  
% within 
Platelet 
count in 
lakhs 
60.0% 40.0%  
% within 
MRI 
Finding 
7.5% 20.0%  
     
    
    
 
Patients with abnormal MRI finding have platelet count of <3 
lakh.p value is 0.447, statistically not significant. 
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LFT 
Table-17: LFT 
 
  
Frequency 
 
Percent 
 
  Normal 49 98.0 
  Altered 1 2.0 
  Total 50 100.0 
 
Out of 50 patients in my study group,only one patient have altered 
liver function test. 
LFT
Altered
Normal
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LFT * MRI FINDING 
 
 
 
    
MRI Finding 
P value Normal
Abnor
mal 
LFT Normal Count 40 9  
% within 
LFT 
81.6% 18.4%  
% within 
MRI 
Finding 
10.0% 90.0%  
Altered Count 0 1 .043** 
% within 
LFT 
.0% 100.0%  
% within 
MRI 
Finding 
.0% 100.0%  
     
    
    
 
In our study group ,the patient with altered liver function test have 
100% abnormal MRI finding. Others with normal LFT have 90% have 
abnormal MRI finding. 
p value is 0.043**,significant. 
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RENAL FUNCTION TEST 
 
Table-18:RFT 
 
  
Frequency 
 
Percent 
 
  Normal 48 96.0 
  Altered 2 4.0 
  Total 50 100.0 
        
In our study group,  Out of 50 patients, only 2 patients have altered 
renal function test.   
 
 
 
RFT
Altered
Normal
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RFT * MRI Finding 
 
    
MRI Finding 
P value Normal 
Abnorm
al 
RFT Normal Count 39 9  
% within 
RFT 81.3% 18.8%  
% within 
MRI 
Finding 
97.5% 90.0%  
Altered Count 1 1  
% within 
RFT 50.0% 50.0% .279 
% within 
MRI 
Finding 
2.5% 10.0%  
     
    
    
 
 Among the patients with altered renal function test,50% have 
normal and 50% have abnormal MRI finding. 
p value is 0.279 ,which is statistically not significant. 
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MAGNESIUM SULPHATE 
 
 
Table-19: MAGNESIUM SULPHATE 
 
  
Frequency 
 
Percent 
 
  Standard 50 100.0 
 
All Eclamptic patients in our study group were treated with 
standard dose of Magnesium Sulphate regimen. 
 
MAG SULP
Standard
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ANTICONVULSANT 
 
Tablet 20- ANTICONVULSANT 
 
  
Frequency 
 
Percent 
 
  Nil 21 42.0 
  Phenytoin 29 58.0 
  Total 50 100.0 
    
       
In our study group only 29 Eclampsia patients were treated with 
Phenytoin in addition to Magnesium sulphate. Remaining 21 patients are 
treated only with Magnesium sulphate.         
 
 
 
Anticonvulsant
Phemytoin
Nil
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Anticonvulsant * MRI Finding  
 
  
 
    
MRI Finding 
P value Normal
Abnor
mal 
Anticonvuls
ant 
Nil Count 15 6  
% within 
Anticonvuls
ant 
71.4% 28.6%  
% within 
MRI 
Finding 
37.5% 60.0%  
Phenytoin Count 25 4 .176 
% within 
Anticonvuls
ant 
86.2% 13.8%  
% within 
MRI 
Finding 
62.5% 40.0%  
     
    
    
 
 
In our study group, among the patients treated with IV Phenytoin 
,62.5% have normal MRI finding. Those who are not treated , have 
37.5% of normal finding and 60% abnormal finding .p value is 
0.176,which is not Significant. 
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MRI FINDING 
  
TABLE-21: MRI FINDING 
 
  
Frequency 
 
Percent 
 
Valid Normal 
40 80.0 
  Abnormal 
10 20.0 
  Total 
50 100.0 
 
 In our study group,80% have normal MRI finding,20% have 
abnormal MRI finding. 
 
MRI Finding
Abnormal
Normal
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MRI FINDING 
 
Table-22: MRI FINDING 
 
 
Frequency 
 
Percent 
 
Normal 40 80.0 
PRES 5 10.0 
Diffuse Cerebral Edema 2 4.0 
Right Temporal  Infarct 1 2.0 
Acute Infarct and  
Subarachnoid Hemmorhage 1 2.0 
Diffuse Cerebral Edema + 
PRES 1 2.0 
Total 50 100.0 
 
Out of 50 Eclampsia patients in our study group,40 patients have 
normal MRI finding.Out of 50, 5 patients are diagnosed as having 
Posterior Reversible Encephalopathy syndrome.2 patients have diffuse 
cerebral edema ,1 patient has Right temporal infarct ,1 patient has 
combination of both Acute infarct and Subarachnoid Hemmorrhage. 
1 patient has both diffuse cerebral edema and PRES. 
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DISCUSSION 
        In this study 50 women with eclampsia were selected according to 
the inclusion exclusion criteria and Magnetic Resonance and Imaging 
was done .The reports were analysed and studied.        
           In our study (Table-1), the most common age group was 21-25 
yrs.58% of the patients falls between 21-25 yrs of age. 
18 % of the patients are >25 yrs of age.24% are below 20yrs of age are  
.50% of the patients between the age group of 21-25 yrs have abnormal 
MRI finding. p value is 0.543 which is statistically not significant. 
       In our study (Table-2) majority of the patients are multigravida, 
which constitutes 60%. 80% of the patients having abnormal MRI 
findings are multigravida. 
           Similarly in a study by Milliez et al majority of the patients are 
multigravida. 
             In our study group (Table-3),54% of the patients have normal 
BMI (19.8-26) .14% are obese with BMI>29.4%.90% of the patients with 
normal BMI have abnormal MRI finding. p value is 0.036 which is 
statistically significant. 
      In our study group (Table-4), majority of the patients are antepartum 
at the time of presentation.20% are postpartum. Majority of the eclampsia 
patients in our study are between 29-36 weeks of gestational age. p value 
is 0.003** which is statistically significant.  
      In our study (table 5) majority had hypertension diagnosed at the time 
of presentation that is 52.5% of the patients had hypertension diagnosed 
only at the time of presentation with eclampsia.66.7%of the patients 
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having abnormal MRI findings presented with eclampsia 1-4 weeks after 
the onset of hypertension. 
      In a study made by chakravarthy et al all the patients except one did 
not have any evidence of pre eclampsia till the last clinical visit. 
      From this we conclude that majority of  the eclampsia patients are 
diagnosed to have hypertension at the time of presentation. 
      In our study group (table 6), 47.5% of the patients with normal MRI 
findings and 40% of the patients with abnormal MRI findings have 
proteinuria of 1+. p value is 0.678 which is statistically not significant. 
      In our study group (table 7), majority of the patients (90%) had 
imminent symptoms, 10% had no imminent symptoms, p value is 0.239 
which is not significant 
       In our study group (table 7) all the patients had seizures.  
       In our study group (table 9) all the patients didn’t have significant 
positive history. 
       In our study group (table 10) 58 % of the patients who are conscious 
had 10% of abnormal MRI findings. 26 % of the patients who are drowsy 
had 40% of abnormal MRI findings. Majority of the patients who are 
having abnormal MRI findings are unconscious (60%). P value is 0.001 
which is statistically significant. Among the patients with normal MRI 
finding,62.5% were unconscious,37.5% were conscious. 
       In our study group (table-11),Patients with systolic blood pressure 
ranging from 161-200mHg,70% have abnormal MRI finding,22.5% have 
normal MRI finding. The patients with systolic blood 
pressure<160mmHg,had majority of normal MRI findings than 
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abnormal.p value is 0.015, which is significant.Hence high systolic blood 
pressures have significant cerebral pathology.  
              In our study group (table 12), the patients with diastolic blood 
pressures>110mmHg have 50% abnormal MRI finding and 47.5% of 
abnormal finding.p value is 0.746 which is statistically not significant. 
               In our study group (table 13),the patients with Mean arterial 
pressure>126 mmHg,have 80% of abnormal MRI findings and 62.5% of 
normal MRI findings.p value is 0.578,which is not significant. 
              In a study done by chakravarthy et al,all patients had systolic BP 
more than 140mmHg and diastolic >100mmHg. 
              In our study group (table 14) the patients with the Grade 1  
hypertensive retinopathy have only 10% of abnormal MRI findings. p 
value is 0.279 which is statistically not significant. 
              In a study done by chakravarthy et al almost all the patients had 
fundus changes. 
              In a study group (table 15) majority of the patients were mildly 
anaemic that is Hb% between 9-11 gm%. These patients have 60 % of 
abnormal MRI findings. Among the patients with Hb 7-9 gm% only 10% 
had abnormal MRI findings. p value is 0.402, which is not significant. 
              In our study group (table 16) patients with more than 3 lakhs of 
platelet count have only 20 % of abnormal MRI findings. Those  with less 
than 3 lakhs of platelet  count had 80 % of abnormal MRI finding. p value 
is 0.447 which is not significant. 
              In a study done by Hira B and Moodley 70% had 
thrombocytopenia.  
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              In our study group (table 17) patients with altered liver function 
test had 100% of abnormal MRI finding. p value is 0.043 which is 
statistically significant. 
             In a study done by Hira B and Moodley 7% of the patients had 
abnormal liver function test . 
              In our study group (table 18) among the patients with altered 
renal function test 50% had normal MRI findings. p value is 0.279 which 
is not significant. 
             Zhu XW done a study in which patients with renal impairment 
were found to be more susceptible to cerebral lesions  
             In our study group (table 19) all the patients were treated with 
standard dose of magnesium sulphate regimen. 
             But in the study done by chakravarthy et al, none of the patients 
were treated by Magnesium Sulphate. All the patients in the study group 
of Chakravarthy et al were managed by neurologists and not by 
obstetricians. 
              In our study group (table 20) those patients who were treated 
with  IV phenytoin in addition to magnesium sulphate had 62.5 % of 
normal MRI findings. Those who were not treated  with IV Phenytoin 
had 60 % of abnormal MRI finding. p value is 0.176 which is not 
statistically significant.  
              In a study done by Chakravarthy et al all patients were treated 
with IV phenytoin. 
               In our study group,(table 21) Out of 50 Eclampsia patients ,40 
patients had normal MRI finding.5 patients are diagnosed as having 
Posterior Reversible Encephalopathy syndrome.2 patients had diffuse 
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cerebral edema ,1 patient had Right temporal infarct ,1 patient had 
combination of both Acute infarct and Subarachnoid Hemmorrhage.1 
patient had both diffuse cerebral edema and PRES. 
                 In the study done by chakravarthy et al all patients(n=8)had 
cerebral odema,3 patients had cerebral hemmorhage(37%) 
                In a study done by Milliez et al out of 18 patients with positive 
MRI findings,3 had cerebrovascular damage,6 had cerebral oedema,9 had 
accentuated cortical sulci leading to the diagnosis of communicating 
hydrocephalus with cortical atrophy. 
                 In a study done by Moodley et al (1993),the most common 
finding was cerebral edema. 
                 In our study group (table 22), the most common finding is 
Posterior Reversible Encephalopathy Syndrome, next is the diffuse 
cerebral oedema. 
                  In our study group,the most common area affected by PRES 
and hemmorhage is parieto occipital region as we discussed earlier 
,posterior circulation is more prone to acute hypertension as it lacks 
perivascular sympathetic nerves . 
                    In a study done by chakravarthy et al, the most affected area 
was occipital region. Brainstem or Basal ganglia is free of lesion. 
                     Zhu XW in his study, stated that cerebral lesions were found 
in cortical and subcortical areas of  bilateral parietal  
and occipital lobes. secondly at deep basal ganglia and the superior 
saggital sinus. 
                      In a study done by Milliez et alno one had diffuse 
involvement. 
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SUMMARY 
                  50 patients with eclampsia between Sep 2015- Dec 2016 at    
Govt.Stanley Medical College, Chennai were selected according to the 
inclusion and exclusion criteria already stated in the methodology were 
for the prospective and retrospective analytical study. 
                   MRI Brain was done for these patient within 1 week of 
postpartum period . 
                    The results were tabulated,analysed and summarized as 
follows. 
1.   Out of 50 eclampsia patients ,20%had pathological findings in the 
MRI of the Brain taken. 
2. Majority of the patients(58%) were in the age group of (21-25 yrs) 
3. Majority of the patients are multigravida(60%) 
4. Majority of the patients(54%)have Normal Body Mass Index of 
19.8-26. 
5. Majority of the patiets are in the antepartum period (80%) at the 
time of presentation. 
6. Majority of the patients had diagnosed hypertension(52.5%) only at 
the time presentation. 
7. Most of the patients had imminent symptoms(90%) 
8. Majority of the patients with positive MRI finding had Proteinuria 
of 1+  
9. Most of the patients had antepartum eclampsia(80%) 
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10. Only in positive MRI finding group 62.5% were unconscious at the 
time of presentation. p value is 0.001 ,hence statistically 
significant. 
 11. In the patients with positive MRI finding ,70% had systolic blood 
pressure between 161-200 mmHg.p value is 0.015 which is 
statistically significant. 
12. In the patients with positive MRI finding 40% of the patients had 
diastolic blood pressure in the range of 90-100mmHg. 50% had 
diastolic blood pressure >110mmHg. 
13. 80% of the patients with positive MRI findings had MAP>126. 
14. Only 10% of patients with positive MRI finding had abnormal 
fundus. 
15. The patients with positive MRI findings had Hb% in the range of 
9-11g%. 
16. In the positive MRI finding group,80% of the patients have had 
their platelet count <3 lakh. 
17.  Of the patients with altered liver function test,100% had positive 
MRI finding, p value is 0.043,hence statistically significant. 
18. Among the patients with altered renal function tests,50% had 
normal and abnormal MRI finding. 
19. In the patients with positive MRI finding,only 40% are treated with 
IV Phenytoin,60% are not treated with IV Phenytoin. 
20. Posterior Reversible Encephalopathy Syndrome was the most 
common  Cerebral pathology. Most common area affected in the 
brain is Parieto occipital region.   
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CONCLUSION 
 
1. 20% of the Eclampsia patients had pathological abnormalities 
detected through MRI scan of Brain. 
2. Patients with altered liver function tests, normal BMI, high Systolic 
blood pressure, Unconscious level are prone for developing 
Cerebral lesions. 
3. Posterior Reversible Encephalopathy Syndrome was the most 
common pathological abnormality detected .The next common is 
the Diffuse Cerebral Edema. 
4. Since majority of the patients had hypertension diagnosed only at 
the time of presenation, the need for effective screening of 
hypertension and its management is emphasized. 
5. Thus it is concluded that MRI brain should be included in the 
investigation protocol for Eclampsia if not for all, atleast for those 
patients with complications. 
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NAME AGE IP NO BMI PARITY GA/PP U.ALB HT AT IMMI SYM SEIZURE PAST H/O CONSCIOUS LEVEL MAX BP MAP FUNDUS HB% PLATELET LFT RFT MAG SULP AC MRI FINDIN
SARALA 30 236 25 G2P1L1 34 1+ 34 H + NO C 160/120 133.3 N 9 2 N N SD P N
RAMADEVI 20 3304 26.31 PRIMI 36 2+ 36 NO + NO C 140/100 113 N 10 3 N N SD P N
JAYANTHI 21 5614 25 PRIMI 37 1+ 37 H + NO D 180/130 147 N 9.7 2.7 N N SD P N
MANJULA 24 4936 25 PRIMI 37 2+ 34 H + NO UC 150/110 123 GR1 12 2.5 N N SD P N
HEMALATHA 20 8694 25.88 PRIMI 37 1+ 37 H + NO C 120/90 100 N 10.3 2.4 N N SD NO N
SUMATHI 23 3774 42 G2P1L0 34 1+ 34 V + NO C 160/120 133 N 9.8 2.6 N N SD NO N
SANGEETHA 24 6064 32 PRIMI 37 1+ 37 NO + NO D 160/90 113 N 9.6 2.8 N N SD P N
SIVARANJANI 21 2526 24.44 PRIMI 30 1+ 30 NO + NO C 170/120 137 N 10.5 1.25 N N SD P N
SANGEETHA 19 3113 22.48 PRIMI 33 2+ 33 H+V + NO C 160/120 133 N 10.2 3.2 N N SD NO N
JAYANTHI 20 3505 31.6 G2A1 35 3+ 33 NO + NO D 160/120 133 N 9.8 2.13 N N SD NO N
HAISHA 21 5655 24.44 PRIMI 33 T 30 NO + NO C 140/100 113 N 8.2 1.2 N N SD P N
HASEENA 20 1235 25 PRIMI 36 2+ 36 H + NO C 160/120 133 N 9.12 1.3 N N SD P N
SUDHA 22 3088 32.47 PRIMI 37 2+ 36 H+V + NO C 150/90 110 N 9.8 1.5 N N SD NO N
JABAKUMARI 27 3300 31.56 G2P1L1 36 1+ 36 H + NO UC 170/100 123 N 8.6 1.2 N N SD P N
POOJA 19 3265 28.48 PRIMI 38 2+ 37 H+V + NO C 160/120 133 N 8.2 1.6 N N SD NO N
GNANASOUNDA 28 2961 32.6 G2P1L1 38 1+ 38 V + NO D 150/110 123 N 10 2.8 N N SD P N
KUMARI 23 4723 22.48 PRIMI 36 2+ 36 H+V + NO C 160/100 120 N 9.4 2.5 N N SD NO N
RAMANI 27 4234 28.57 PRIMI 35 2+ 35 H + NO D 160/120 133 N 9.2 1.8 N N SD P N
JEMIMA 21 3234 23.01 G2A1 31 2+ 30 BOV + NO C 150/100 117 N 9.8 2 N N SD P N
BALAABIRAMI 22 7312 24.45 G3P1L1A1 28 3+ 28 V,H,BOV + NO D 170/120 137 N 13.2 2.47 N N SD NO F1
EZHILARASI 19 10567 20.81 P1L1A1 PP 1+ PP H+E + NO C 160/120 133 N 7.8 1.76 N N SD P N
THAJUNISHA 24 6675 22.83 PRIMI 27 3+ 28 H + NO C 180/110 133 N 9.9 4 R N SD P F2+F1
SASIKALA 23 7938 29.76 G2P1L1 38 1+ 38 H + NO C 160/110 127 N 12.6 1.92 N N SD P N
VAIJAYANTHI 21 7391 28.31 G2A1 32 2+ 32 V + NO D 160/120 133 N 9.2 2.1 N N SD P N
HEMAVATHY 23 3836 29.7 P1L1 PP 1+ PP H + NO C 170/110 130 N 11.6 2.82 N N SD P N
VANITHA 34 7023 23.24 P2L2 PP 2+ PP H + NO D 160/120 133 N 8.6 1.78 N N SD NO F1
SOUNDARYA 18 9701 20.41 P1L1 PP 1+ PP H + NO D 170/100 123 N 12.1 2.54 N N SD NO F4+F5
RESHMA 27 11078 23.19 G3P1L1A1 34 2+ 32 H + NO UC 160/120 133 N 10.2 2.4 N N SD P F3
SOUNDARYA 21 8297 22.84 P1L1 PP 2+ PP V + NO UC 140/100 113 N 9.2 2.5 N N SD NO F1
HARITHA 19 9814 25.43 PRIMI 36 1+ 36 V + NO C 160/120 133 N 9.7 2.4 N N SD P N
SHANVAS 18 3932 19.81 P1L1 PP 1+ PP H + NO UC 190/130 150 N 9.2 1.5 N N SD P F1
PONNI 22 4113 24.56 P1L1 PP 3+ PP H + NO C 160/120 133 N 9.5 2.15 N N SD NO N
SARANYA 26 4556 25.3 P2L3 PP 2+ PP H + NO D 180/110 133 N 10.1 2.5 N N SD P N
VIDHYA 20 5221 26.04 PRIMI 36 1+ 34 H+V + NO C 150/90 110 N 12.3 2.6 N N SD NO N
BOOMA 23 4576 26.84 G2P1L1 28 2+ 28 H + NO UC 180/100 127 N 10.4 3.4 N N SD P F1
KAUSALYA 24 6767 23.37 G2A1 35 1+ 32 H + NO C 160/120 133 N 11 3.2 N N SD NO N
PRIYA 22 3431 25.79 G2P1L1 36 2+ 37 H+V + NO C 150/100 117 N 10.6 2.3 N N SD NO N
JEEVITHA 28 5621 20 G3P1L1A1 34 2+ 36 V + NO C 150/110 123 N 9.4 2.1 N N SD NO N
DIANA 23 3432 20.31 G2A1 30 3+ 30 BOV + NO D 160/120 133 N 10.1 1.6 N N SD P N
VINODHA 21 8767 24.84 PRIMI 37 1+ 36 H + NO C 150/120 130 N 9.2 1.5 N N SD P N
GEETHA 22 4443 23.62 G2A1 36 1+ 32 H + NO UC 180/100 127 GR1 9.4 1.1 N N SD NO F2
ANITHA 23 1112 21.93 P2L2 PP 2+ PP H+V + NO C 160/120 133 N 9.2 2.3 N N SD P N
LAVANYA 18 2334 23.01 PRIMI 32 1+ 30 H + NO UC 190/100 130 N 9.9 2.5 N N SD P N
PARVEEN 24 2465 22.43 G3P1L1A1 34 2+ 32 H + NO C 140/100 113 N 10.4 3.2 N N SD NO N
MONISHA 25 2112 20.58 P2L1 PP 1+ PP V + NO C 200/120 147 N 11.1 2.3 N N SD P N
DEIVANAI 24 2133 21.09 G2P1L1 24 2+ 24 H + NO C 160/120 133 N 10.2 1.8 N N SD P N
RADHA 26 2213 21.63 PRIMI 32 1+ 30 H+V + NO D 180/120 140 N 12 1.3 N N SD NO F2
VICTORIA 25 12086 33.29 G3P2L2 33 3+ 33 V + NO D 170/100 123 N 10.4 1.7 N N SD NO N 
KAMATCHI 21 12176 21.34 G2A1 38 1+ 35 H + NO C 160/110 127 N 11 2.3 N N SD P N
DIVYA 22 12090 23.74 PRIMI 38 2+ 33 H + NO C 180/110 133 N 10.2 2.24 N N SD NO N
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 நான் இவ்வாய்வில் தன்னிச்ைசயாகத்தான் 
பங்ேகற்கிேறன். எந்த காரணத்தினாலும் எந்த கட்டத்திலும் 
எந்த சட்டசிக்கலும் இன்றி இந்த ஆய்விலிருந்து விலகிக் 
ெகாள்ளலாம் என்றும் அறிந்து ெகாண்ேடன். 
 நான் ஆய்விலிருந்து விலகிக்ெகாண்டாலும் 
ஆய்வாளƫ என்னுைடய மருத்துவ அறிக்ைககைள 
பாƫப்பதற்ேகா அல்லது உபேயாகிக்கேவா என் அனுமதி 
ேதைவயில்ைல எனவும் அறிந்து ெகாண்ேடன் என்ைன 
பற்றிய தகவல்கள் ரகசியமாக பாதுகாக்ப்படும் என்பைதயும் 
அறிேவன். 
 இந்த ஆய்வின் மூலம் கிைடக்கும் தகவல்கைளயும் 
பrேசாதைன முடிவுகைளயும் ஆய்வாளƫ அவƫ 
விருப்பத்திற்ேகற்ப பயன்படுத்திக் ெகாள்ளவும் அதைன 
பிரசுrக்கவும் முழுமனதுடன் சம்மதிக்கிேறன். 
 இந்த ஆய்வில் பங்கு ெகாள்ள ஒப்புக்ெகாள்கிேறன் 
எனக்கு ெகாடுக்கப்பட்டுள்ள அறிவுைரகளின்படி நடந்து 
ெகாள்வதுடன் ஆய்வாளருக்கு உண்ைமயுடன் இருப்ேபன், 
என்றும் உறுதி அளிக்கிேறன். 
 உடல்நலம் பாதிக்கப்பட்டாேலா வழக்கத்திற்கு மாறான 
ஏேதனும் ேநாய்குறி ெதன்பட்டாேலா அதைன ெதrவிப்ேபன் 
என்றும் உறுதி கூறுகிேறன். 
 
 இந்த ஆய்வில் எனக்கு எவ்விதமான 
பrேசாதைனகைளயும் சிகிச்ைசகைளயும் ேமற்ெகாள்ள 
நான் முழுமனதுடன் சம்மதிக்கிேறன். 
 இந்த ஆய்வுக்கு ேதைவப்பட்டால் முதலைமச்சrன் 
மருத்துவ காப்பீட்டுத்திட்டத்தில் இருந்து நிதி உதவிைய 
பயன் படுத்திக் ெகாள்ள சம்மதிக்கிேறன்.  
 
                                              
இப்படிக்கு, 
 
 
 
 
ஆய்வாளrன் ைகெயாப்பம்      ேநாயாளியின் ைகெயாப்பம் 
 
  
  
                                                
CONSENT FORM 
 
I agree to participate in the study entitled ‘ANALYTICAL STUDY OF 
MRI BRAIN IN ANTEPARTUM AND POSTPARTIM  ECLAMPSIA 
PATIENTS” 
I agree to give my MRI Brain report for this study 
I confirm that I have been told about this study in my mother tongue and 
have had the opportunity to clarify my doubts. 
I understand that my participation is voluntary and I may refuse to 
participate at any time without giving any reasons and without affecting my 
benifits. 
I agree not to restrict the use of any data or results that arise from this 
study. 
 
 
 
Name of the participant : 
Sign / Thumb print: 
Sign of Investigator : 
 
PROFORMA 
 
                                                                               DATE: 
NAME:                                                                              AGE:                         LMP: 
 IP NO:                                                                                                                EDD: 
D.O.A:                                                     D.O.D                                                 OBSTETRIC 
CODE: 
ADDRESS & CONTACT NO: 
 
 
PRESENTING  COMPLAINTS: 
 
 
MENSTRUAL  HISTORY :                                                                              MD SINCE: 
OBSTETRIC HISTORY: 
 
 
PAST HISTORY: 
 
GENERAL  EXAMINATION: 
HT:             WT:             BMI:           TEMP:                 PR:                             BP:                    
PALLOR:                                            PEDAL EDEMA: 
CVS:                                               RS: 
P/A:                                                                                          
CNS: 
Pupils:  
GCS:                                                                         Reflexes: 
                                                                                  Deep tendon reflexes: 
                                                                                  Plantar Reflex:     
INVESTIGATIONS: 
 
 COMPLETE HEMOGRAM: 
Hb 
Packed cell volume: 
Tc:                           Dc:                 Platelets: 
RBC:                         
WBC:   
Random blood sugar:                  
RENAL FUNCTION TEST: 
 BLOOD UREA:                      
 SERUM CREATININE: 
LIVER FUNCTION TEST: 
TOTAL BILIRUBIN:                        DIRECT BILIRUBIN:                               INDIRECT 
BILIRUBIN: 
SGOT:                   SGPT:                         SAP:                   TOTAL PROTEIN: 
SERUM ALBUMIN:                                   
COAGULATION PROFILE: 
BLEEDING TIME: 
CLOTTING TIME: 
SERUM FIBRINOGEN:                           
PT:          INR:             aPTT:                     
 
 
SERUM ELECTROLYTES: 
SODIUM:                                 
POTASSIUM: 
      
 
  
 
  
 
MRI BRAIN: 
  
 
TREATMENT: 
 
 
 
STAY IN HOSPITAL: 
 
 
 
OUTCOME: 
 
  
  
  
RESULT: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS 
 
BP  - Blood Pressure 
MRI  - Magnetic Resonance and Imaging 
ALT  - Alanine Transaminase 
AST  - Aspartate Transaminase 
 PGI2  -  Prostaglandins 
ROS  - Reactive Oxygen Species 
VCAM  - Vascular Cell Adhesion Molecule 
HLA  -  Human Leucocyte Antigen 
DIC  - Disseminated Intravascular Coagulation 
CT  -  Computed Tomography 
SPECT  - Single Photon Emission Computed Tomography 
DWI  -  Diffusion Weighted Images 
ADC  -  Apparent Diffusion Coefficient 
AT II  -  Angiotensin II 
MAP  -  Mean Arterial Pressure 
BMI  - Body Mass Index 
LFT  -  Liver Function Test 
RFT  -  Renal Function Test 
 
 
KEY TO MASTER CHART 
H HEADACHE 
V  VOMITING 
E EPIGASTRIC PAIN 
BOV BLURRING OF VISION 
D  DROWSY 
UC UNCONSCIOUS 
C CONSCIOUS 
N NORMAL 
SD STANDARD DOSE REGIMEN 
GA GESTATIONAL AGE 
PP POSTPARTUM 
HT AT HYPERTENSION  AT 
U.ALB URINE ALBUMIN 
 MAG.SULP -MAGNESIUM SULPHATE 
AC-ANTICONVULSANT 
MAP-MEAN ARTERIAL PRESSURE 
P-PHENYTOIN 
IMM- IMMINENT SYMPTOM 
 
F1-  PRES (Posterior Reversible Encephalopathy Syndrome) 
F2-DIFFUSE CEREBRAL EDEMA+PRES  
F3-RIGHT TEMPORAL  INFARCT  
F4-ACUTE INFARCT + SUBARACHNOID HEMMORHAGE 
 
 
 
 
